424 Laponite Makes BMP-2 Go Further: Stronger Osteogenesis at a Fraction of the Dose
British Journal of Surgery · 10.07.2026 · 113 (Supplement_6)
DOI: 10.1093/bjs/znag063.454 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Surgery, online erschienen am 10.07.2026. Verfasst von A S Dahil und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
Bone morphogenetic protein-2 (BMP-2) is a potent osteoinductive factor used in fracture healing and spinal arthrodesis. However, its application requires high doses, causing adverse effects including inflammation and ectopic ossification. Nanoclay-based Laponite powder promotes skeletal stem cell differentiation, offering a promising alternative to current BMP-2 delivery systems. However, the effects of BMP-2's localisation on Laponite particles remains unexplored. This study evaluates the effectiveness of Laponite to enhance BMP-2's bioactivity while limiting systemic exposure.
Method
Serial dilutions (640 ng/mL to 0 ng/mL) of BMP-2 were introduced to C2C12 myoblasts under four conditions: (A1) freeze-dried BMP-2 with freeze-dried Laponite, (A2) freeze-dried BMP-2 alone, (B1) BMP-2 with Laponite, and (B2) BMP-2 alone. The formulations were incubated for 72 hours. Alkaline phosphatase (ALP) activity, a marker of osteogenic differentiation, was quantified via biochemical staining and image analysis. Statistical analysis included two-way ANOVA.
Results
Laponite significantly enhanced BMP-2's bioactivity, with higher ALP activity in groups mixed with Laponite (A1 vs. A2, p<0.0001, B1 vs. B2, p<0.0001). Non-freeze dried formulations of Laponite with BMP-2 resulted in superior osteogenic stimulation compared to freeze-dried formulations (A1 vs. B1 p <0.0001). BMP-2 demonstrated osteoinductive activity at 10 ng/mL, the lowest concentration tested to date, suggesting that lower doses could still be clinically effective.
Conclusions
Laponite enhances BMP-2's osteoinductive activity, supporting its use as biomaterials for bone regeneration. Laponite’s ability to induce bone formation at lower BMP-2 concentrations suggests clinical benefits in fracture healing. Future studies will integrate BMP-2 loaded Laponite into human bone derived extracellular matrix hydrogels.
Zitieren
APA
Dahil, A. S., & Pinn, C. (2026). 424 Laponite Makes BMP-2 Go Further: Stronger Osteogenesis at a Fraction of the Dose. British Journal of Surgery, 113(Supplement_6). https://doi.org/10.1093/bjs/znag063.454
Vancouver
Dahil AS, Pinn C. 424 Laponite Makes BMP-2 Go Further: Stronger Osteogenesis at a Fraction of the Dose. British Journal of Surgery. 2026;113(Supplement_6). doi:10.1093/bjs/znag063.454
BibTeX
@article{Dahil2026,
author = {Dahil, A S and Pinn, C},
title = {424 Laponite Makes BMP-2 Go Further: Stronger Osteogenesis at a Fraction of the Dose},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_6},
doi = {10.1093/bjs/znag063.454}
}
EUVIMED